Every recall we track for Orexigen Therapeutics, Inc. — 2 in all, all from 2018 — plus the complaints and injury reports the public filed about them.
Orexigen recalls Contrave (naltrexone HCl and bupropion HCl) 8mg/90mg tablets due to container packaging defect. Rx-only 120-count bottles with specific lot number and expiration date.
Orexigen recalls Contrave 8mg/90mg tablets due to customer reports of bottle punctures. Affected lots expire Nov 2020. Stop using if you have these bottles.
2 recalls from Orexigen Therapeutics, Inc. are on record with U.S. safety agencies, from 2018.
Orexigen Therapeutics, Inc. recalls Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only,, dated Oct 5, 2018. Every Orexigen Therapeutics, Inc. recall is listed on this page, newest first.
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
